Article Details
Retrieved on: 2021-03-31 09:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Fresh from a licensing agreement with Pfizer, US startup Pyxis Oncology has raised a sizeable $152 million in second-round financing led by venture ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here